�鶹��ýӰ��

Nicole Lou

Nicole Lou

Authors >

Nicole Lou

Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. She is also a producer on the Anamnesis podcast team. Her work has previously appeared in TCTMD, Popular Science, Audubon Magazine, The Atlantic, and more. Nicole received her M.A. in science journalism from New York University’s Science, Health and Environmental Reporting Program and her B.A. in Spanish and biology from Williams College. She is based in New York City.

Connect:

email image

Latest from Nicole Lou

ESC over a photo of ExCeL London conference and exhibition center.

Oral Anticoagulation and TAVR Together: A Recipe for Trouble

Continued OAC failed to meet noninferiority in POPular PAUSE TAVI

Cardio Break over a computer rendering of a heart.

TAVR's Win in Women; Chest Pressure During Cardioversion; Doc Goes to Space

Recent developments of interest in cardiovascular medicine

ESC over a photo of ExCeL London conference and exhibition center.

Invasive Strategy for NSTEMI in the Elderly: Fears Don't Pan Out in SENIOR-RITA

Trial paints a fuller picture of risk-benefit in complex patient population

ESC over a photo of ExCeL London conference and exhibition center.

Afib Ablation Delivers in First Sham-Controlled Study

More conclusive evidence for benefits on Afib burden, QoL

ESC over a photo of ExCeL London conference and exhibition center.

Stenting, TAVR Make Sense Packaged Together for Some Patients

NOTION-3 trial informs care for those with severe AS and stable CAD

ESC over a photo of ExCeL London conference and exhibition center.

Another Trial Sides With MitraClip for Functional Mitral Regurgitation

RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates

ESC over a photo of ExCeL London conference and exhibition center.

Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick.

Either choice is "acceptable" based on randomized study

ESC over a photo of ExCeL London conference and exhibition center.

Stopping Beta-Blockers Did Not Go as Planned for Long-Time Users

No benefit to beta-blocker interruption among MI survivors using them for secondary prevention

ESC over a photo of ExCeL London conference and exhibition center.

Wegovy Protects Against Deadly COVID Cases

Non-cardiovascular benefits observed in SELECT trial

Cardio Break over a computer rendering of a heart.

Clot Grabber IFU Recall; Free Cholesterol Tests at CVS; Naloxone for Cardiac Arrests

Recent developments of interest in cardiovascular medicine

…

8

…